339 related articles for article (PubMed ID: 36810108)
21. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility.
Cai Z; Niu Y; Li H
Mol Hum Reprod; 2021 May; 27(6):. PubMed ID: 33749751
[TBL] [Abstract][Full Text] [Related]
22. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Viral Infection by the RNA Modification
Williams GD; Gokhale NS; Horner SM
Annu Rev Virol; 2019 Sep; 6(1):235-253. PubMed ID: 31283446
[TBL] [Abstract][Full Text] [Related]
24. N
Zheng S; Han H; Lin S
Cancer Biol Med; 2022 Mar; 19(4):385-97. PubMed ID: 35254013
[TBL] [Abstract][Full Text] [Related]
25. N6-methyladenosine (m6A) modification in gynecological malignancies.
Zhang C; Liu N
J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
[TBL] [Abstract][Full Text] [Related]
26. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
Front Immunol; 2022; 13():819080. PubMed ID: 35359993
[TBL] [Abstract][Full Text] [Related]
27. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
28. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
29. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
30. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
31. Characterization of m
Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
Front Immunol; 2021; 12():782551. PubMed ID: 34975871
[TBL] [Abstract][Full Text] [Related]
32. Potential roles of N6-methyladenosine (m6A) in immune cells.
Liu C; Yang Z; Li R; Wu Y; Chi M; Gao S; Sun X; Meng X; Wang B
J Transl Med; 2021 Jun; 19(1):251. PubMed ID: 34103054
[TBL] [Abstract][Full Text] [Related]
33. Emerging roles of m6A RNA modification in cancer therapeutic resistance.
Liu WW; Zhang ZY; Wang F; Wang H
Exp Hematol Oncol; 2023 Feb; 12(1):21. PubMed ID: 36810281
[TBL] [Abstract][Full Text] [Related]
34. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Chen M; Wong CM
Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
[No Abstract] [Full Text] [Related]
36. Functions of RNA N
Zheng X; Gong Y
Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
[TBL] [Abstract][Full Text] [Related]
37. N
Zhan L; Zhang J; Zhu S; Liu X; Zhang J; Wang W; Fan Y; Sun S; Wei B; Cao Y
Front Cell Dev Biol; 2021; 9():736298. PubMed ID: 34616742
[TBL] [Abstract][Full Text] [Related]
38. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():765723. PubMed ID: 35003079
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated N6-methyladenosine (m
Wang YF; Ge CM; Yin HZ; Dai ZH; Dong JP; Ji M; Yang F
Ann Hepatol; 2021; 25():100538. PubMed ID: 34555511
[TBL] [Abstract][Full Text] [Related]
40. Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy.
Guan A; Wong JJ
Cancer Med; 2024 Apr; 13(7):e6989. PubMed ID: 38545841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
